Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers.
10.3904/kjim.2005.20.4.317
- Author:
Gwang Ha KIM
1
;
Dong Hyun LEE
;
Hyung Wook KIM
;
Jong Yun CHEONG
;
Soo Boon SEO
;
Jeong HEO
;
Dae Hwan KANG
;
Geun Am SONG
;
Mong CHO
;
Ung Suk YANG
;
Do Youn PARK
;
Mi Ae YOO
Author Information
1. Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea. doc0224@chol.com
- Publication Type:Original Article
- Keywords:
Colorectal cancers;
Homeobox genes;
CDX1;
CDX2;
Expression
- MeSH:
RNA, Messenger/*metabolism;
Polymerase Chain Reaction;
Middle Aged;
Male;
Humans;
Homeodomain Proteins/*metabolism;
Female;
Colorectal Neoplasms/*metabolism
- From:The Korean Journal of Internal Medicine
2005;20(4):317-324
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: CDX1 and CDX2 are members of the caudal-type homeobox gene family and control the proliferation and differentiation of intestinal mucosal cells. Their expressions are commonly reduced in colorectal cancer, but reports about the relationships between their expressions and clinicopathologic features are rare. The aim of this study was to examine the expressions of CDX1 and CDX2 mRNAs in colorectal cancers and to assess the relationships between their expressions and clinicopathologic features. METHODS: CDX1 and CDX2 mRNA expressions were analyzed by real-time polymerase chain reaction in 48 colorectal cancers and in adjacent non-tumorous normal mucosal tissue. RESULTS: CDX1 and CDX2 mRNA expressions were significantly reduced in colorectal cancer tissues versus normal mucosal tissues (p=0.001, p=0.042, respectively). As compared with paired normal mucosal tissues, colorectal tissues showed reduced CDX1 mRNA expression in 64.6% (31/48) and reduced CDX2 mRNA expression in 66.7% (32/48) of cases. A statistically significant positive correlation was found between the expressions of CDX1 mRNA and CDX2 mRNA in colorectal cancer (r=0.543, p< 0.001). However, the expressions of CDX1 and CDX2 mRNAs were not related to age, sex, cancer location, differentiation, lymphatic or vascular invasion, lymph node metastasis, stage or serum carcinoembryonic antigen level. CONCLUSIONS: CDX1 and CDX2 mRNA expressions were found to be significantly reduced in colorectal cancers, but these expressional changes were not found to be related to clinicopathologic features.
